Contract DevelopmentsEHAB now has a new contract with UNH, which is expected to positively impact future performance.
EarningsThe price target for the stock was raised, reflecting an increase in EBITDA forecasts.
Revenue GrowthThe company's operations are seen as relatively unaffected by political, regulatory, and budgetary issues impacting the broader healthcare sector, enhancing its defensive appeal.